US Stock MarketDetailed Quotes
JSPRW JASPER THERAPEUTICS INC C/WTS 01/12/2026 (TO PUR COM)
Watchlist
0.0650
-0.0321-33.06% Close 09/22 16:00 ET
0.0650High0.0650Low400Volume
0.0650Open0.0971Pre Close28.00Turnover0.00%Turnover Ratio0.00P/E (TTM)0Market Cap0.253452wk High1.48P/E (Static)0Shares0.016052wk Low0.00P/B0Float Cap2.2400Historical High--Dividend TTM0Shs Float0.0160Historical Low--Div YieldTTM0.00%Amplitude0.0700Avg Price1Lot Size
JASPER THERAPEUTICS INC C/WTS 01/12/2026 (TO PUR COM) Key Stats
Quarterly+Annual
YOY

(Q2)2023/06/30 | (Q1)2023/03/31 | (FY)2022/12/31 | (Q4)2022/12/31 | (Q3)2022/09/30 | (Q2)2022/06/30 | (Q1)2022/03/31 | (FY)2021/12/31 | (Q4)2021/12/31 | (Q3)2021/09/30 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -41.86%-13.27M | 27.28%-10.34M | -36.17%-45.86M | 13.29%-12.65M | -35.66%-9.64M | -61.56%-9.36M | -129.43%-14.21M | -84.37%-33.68M | -170.42%-14.58M | -7.11M |
Net income from continuing operations | -54.56%-16.08M | -546.13%-14.26M | -23.00%-37.69M | -45.87%-13.21M | -247.68%-11.86M | -23.65%-10.4M | 77.37%-2.21M | 3.26%-30.64M | 9.31%-9.06M | ---3.41M |
Operating gains losses | --0 | 109.50%575K | -339.92%-7.2M | -200.00%-150K | 65.56%-155K | ---845K | -272.81%-6.05M | -72.40%3M | -101.25%-50K | ---450K |
Depreciation and amortization | 26.15%275K | 26.85%274K | 158.62%975K | 40.72%273K | 103.03%268K | 651.72%218K | 881.82%216K | --377K | --194K | --132K |
Other non cash items | 40.00%-318K | 119.02%863K | 40.69%-5.39M | 100.30%9K | 94.69%-332K | -702.27%-530K | -4,826.04%-4.54M | -43,376.19%-9.09M | ---3.02M | ---6.26M |
Change In working capital | 28.07%1.46M | 139.20%946K | -140.04%-649K | 59.44%-1.17M | -33.12%1.8M | -48.44%1.14M | -523.51%-2.41M | 25.08%1.62M | -2,409.60%-2.89M | --2.68M |
-Change in receivables | --0 | --663K | -210.50%-663K | ---663K | --0 | --0 | --0 | --600K | --0 | --0 |
-Change in prepaid assets | -61.92%353K | -7.81%-290K | 114.10%312K | 29.54%-1.36M | 162.60%1.01M | 713.16%927K | 65.73%-269K | -795.55%-2.21M | -421.00%-1.93M | --385K |
-Change in payables and accrued expense | 488.83%1.05M | 136.82%761K | -133.74%-1.32M | 3.54%-381K | -37.57%954K | -93.97%179K | -918.23%-2.07M | 146.18%3.9M | -2,733.33%-395K | --1.53M |
-Change in other current assets | 723.53%280K | 0.00%34K | 67.15%-114K | 37.75%-216K | -94.92%34K | 105.08%34K | --34K | -38.80%-347K | -16.44%-347K | --669K |
-Change in other current liabilities | ---227K | -100.00%-222K | 456.78%1.13M | 760.27%1.45M | -300.00%-204K | --0 | -11,200.00%-111K | -250.95%-317K | -14.06%-219K | --102K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -41.86%-13.27M | 27.28%-10.34M | -36.17%-45.86M | 13.29%-12.65M | -35.66%-9.64M | -61.56%-9.36M | -129.43%-14.21M | -84.37%-33.68M | -170.42%-14.58M | ---7.11M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 95.47%-11K | 10.34%-26K | 76.28%-576K | 88.47%-82K | 52.77%-222K | 15.33%-243K | 96.98%-29K | -2.43M | -711K | -470K |
Net PPE purchase and sale | 95.47%-11K | 10.34%-26K | 76.28%-576K | 88.47%-82K | 52.77%-222K | 15.33%-243K | 96.98%-29K | ---2.43M | ---711K | ---470K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 95.47%-11K | 10.34%-26K | 76.28%-576K | 88.47%-82K | 52.77%-222K | 15.33%-243K | 96.98%-29K | ---2.43M | ---711K | ---470K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -2,446.15%-305K | 780,753.85%101.51M | -99.95%55K | 103.08%28K | -100.00%1K | 102.17%13K | -99.88%13K | 794.56%100.97M | -108.41%-909K | 91.73M |
Net common stock issuance | --0 | --101.48M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net preferred stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -4.31%10.75M | --0 | --0 |
Proceeds from stock option exercised by employees | 2,638.46%356K | 146.15%32K | -76.69%55K | -17.65%28K | -99.24%1K | -80.88%13K | 550.00%13K | 345.28%236K | -35.85%34K | --132K |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --89.98M | ---943K | --91.59M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -2,446.15%-305K | 780,753.85%101.51M | -99.95%55K | 103.08%28K | -100.00%1K | 102.17%13K | -99.88%13K | 794.56%100.97M | -108.41%-909K | --91.73M |
Net cash flow | ||||||||||
Beginning cash position | 83.31%129.82M | -54.53%38.67M | 321.37%85.05M | -49.27%51.37M | 258.03%61.23M | 197.80%70.82M | 321.37%85.05M | -25.70%20.18M | 585.37%101.25M | --17.1M |
Current changes in cash | -41.75%-13.59M | 740.59%91.15M | -171.50%-46.38M | 21.62%-12.7M | -111.72%-9.86M | -43.55%-9.59M | -495.58%-14.23M | 1,029.27%64.86M | -399.52%-16.2M | --84.15M |
End cash Position | 89.82%116.23M | 83.31%129.82M | -54.53%38.67M | -54.53%38.67M | -49.27%51.37M | 258.03%61.23M | 197.80%70.82M | 321.37%85.05M | 321.37%85.05M | --101.25M |
Free cash flow | -38.38%-13.28M | 27.25%-10.36M | -28.60%-46.43M | 16.78%-12.73M | -30.18%-9.87M | -57.93%-9.6M | -99.05%-14.24M | -97.66%-36.11M | -183.61%-15.3M | ---7.58M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--